Study paves the way for improving personalized treatment of

A study led by the ITACA Institute of the Universitat Politècnica de València, with the participation of the Institut Català d'Oncologia (ICO), the Institut Investigació Germans Trias I Pujol (IGTP) and the Hospital Clinic de Barcelona, opens up a novel approach for improving personalized treatments for patients with glioblastoma, one of the most aggressive types of cancer in existence today.

Related Keywords

Barcelona , Comunidad Autonoma De Cataluna , Spain , Germany , New York , United States , Columbia University , Germans , Institut Investigaci , Triasi Pujol , Institut Catal , Biomedical Data Science Lab Bdslab , Institute Of The Universitat Polit , Universitat Polit , Germans Triasi Pujol , Hospital Clinic De Barcelona , Del Mar , Biomedical Data Science Lab , Glioblastoma , Evacizumab , Flood , Blood Vessels , Dancer , Efficacy , Research ,